Mufg Securities Americas Inc. made a modest splash in the biotech pool, acquiring 1,554 shares of Regeneron Pharmaceuticals ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.

Deutsche Bank AG boosted its stake in Regeneron Pharmaceuticals by nearly 22% in Q4, now holding 539,269 shares valued at ...

With President Donald Trump expected to deliver a drug pricing order on Monday that Big Pharma and patient groups alike have ...

Fintel reports that on May 7, 2025, Leerink Partners upgraded their outlook for Amylyx Pharmaceuticals (NasdaqGS:AMLX) from Market Perform to Outperform. Analyst Price Forecast Suggests 93.03% ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Fintel reports that on May 7, 2025, Leerink Partners upgraded their outlook for Amylyx Pharmaceuticals (NasdaqGS:AMLX) from Market Perform to Outperform. As of May 7, 2025, the average one-year ...

Royal Bank of Canada dropped their price objective on Regeneron Pharmaceuticals from $1,051.00 to $943.00 and set an “outperform” rating on the stock in a report on Wednesday. Leerink Partners ...

Canaccord Genuity Group raised Regeneron Pharmaceuticals from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, April 22nd. Leerink Partnrs raised shares of Regeneron ...

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...